Amgen ($AMGN) is investing an additional $300 million to expand its biologics manufacturing facility in Puerto Rico, bringing its recent commitments to the site to nearly $1 billion as drugmakers increase...
Barchart Research What to Expect from NVS Earnings NVS Generated April 27, 2026 Current Price $144.19 EPS Estimate $$2.11 Consensus Rating Moderate Buy Average Move 2.66% Can Novartis Prove Its Pipeline...
Monday U.S. Featured Earnings Verizon Communications Inc (NYSE:VZ) (Q1) EPS of $1.22, ...
With uncertainty plaguing the market, investors might be more inclined than usual to seek out low-volatility alternatives. These ETFs take multiple approaches.
Pharmaceutical giant Novartis (NVS) is purchasing privately held biotechnology firm Excellergy for $2 ...
With oil prices soaring near $100 per barrel, certain sectors are feeling more pain than others. Here are three ETFs to avoid amid oil's market roil.
Novartis (NVS) is trading at new all-time highs on Monday. Shares are up nearly 50% over the past 52 weeks. NVS maintains a 100% “Buy” technical opinion from Barchart. Novartis has benefitted in recent...
'Sell America' fear is rising again, and this non-U.S. ETF could be a wise buy to stay diversified and invested globally while U.S. policy risks swirl.
Salesforce (NYSE: CRM) , the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS) , a leading global innovative medicines company, has selected Salesforce’s...
The S&P 500 Index ($SPX ) (SPY ) on Monday rose by +1.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose by +1.82%. December E-mini S&P...